Rosiglitazone - wikipedia, the free encyclopedia, Rosiglitazone (trade name avandia, glaxosmithkline) is an antidiabetic drug in the thiazolidinedione class of drugs. it works as an insulin sensitizer, by binding to. Glaxosmithkline to pay $3 billion for diabetes drug scam, By dr. mercola. drugmaker glaxosmithkline has preliminarily agreed to a $3 billion settlement over the sales and marketing practices of several of its drugs. Fda decides to curb avandia but is it enough?, Like vioxx, the case of avandia has turned into yet another classic example of what is fundamentally wrong with the conventional medical paradigm..
Press announcements - food and drug administration, Note: press announcements from 2004 to 2009 are available through the fda archive. some links in press announcements may no longer be active. for more information. Lawsuit settlement news website reports update on, Pr newswire - prf get email alerts lawsuit settlement news website reports update on risperdal litigation due to increase of filed cases. Fda fast-track programs for drugs and medical devices, These four fast track options apply to drugs only, but medical devices have their own speedy process called the 510(k) premarket notification program..
Alabama confidential: us court revives lawsuit against, From the story--a lawsuit claiming an alabama coal company executive paid paramilitary forces to kill three colombian union leaders was revived thursday. Latest news headlines - nasdaq.com - nasdaq stock market, Find all the latest news headlines in the stock market today features general financial news, forex news, options news, and more.. Yaz settlement: when will yaz or yasmin settlements occur?, Settlement agreements have been reached in thousands of yaz injury lawsuits and yasmin injury lawsuits filed by women throughout the united states, and negotiations.